39:13
Impurities in Drug Substances/Products: Global Guidances & USP Perspective
Impuirites Mp3 & Mp4
39:13
05:55
ICH M7 - Risk assessment for mutagenic impurities and control strategies
01:42
AASHTO T 21 - Organic Impurities
26:07
How to define limit for unknown, known and total impurities
07:27
Identified Impurity,Unidentified Impurity, Specified Impurity , Unspecified Impurity as per ICH Q3A
02:23
Tackling nitrosamine impurities in medicines
03:57
Nitrosamine impurities in Pharmaceutical industry l 10 basic and important Interview Question
17:19
Nitrosamines impurities by M. Filancia (EMA)
12:22
Mutagenic Impurities from a Drug Substance Perspective: Highlights from ICH M7 Q&A Draft Document
41:52
Technical Tuesday: Nitrosamines Impurities